Cannabinoid CB(2) receptor ligand profiling reveals biased signalling and off-target activity

The cannabinoid CB(2) receptor (CB(2)R) represents a promising therapeutic target for various forms of tissue injury and inflammatory diseases. Although numerous compounds have been developed and widely used to target CB(2)R, their selectivity, molecular mode of action and pharmacokinetic properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Soethoudt, Marjolein, Grether, Uwe, Fingerle, Jürgen, Grim, Travis W., Fezza, Filomena, de Petrocellis, Luciano, Ullmer, Christoph, Rothenhäusler, Benno, Perret, Camille, van Gils, Noortje, Finlay, David, MacDonald, Christa, Chicca, Andrea, Gens, Marianela Dalghi, Stuart, Jordyn, de Vries, Henk, Mastrangelo, Nicolina, Xia, Lizi, Alachouzos, Georgios, Baggelaar, Marc P., Martella, Andrea, Mock, Elliot D., Deng, Hui, Heitman, Laura H., Connor, Mark, Di Marzo, Vincenzo, Gertsch, Jürg, Lichtman, Aron H., Maccarrone, Mauro, Pacher, Pal, Glass, Michelle, van der Stelt, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216056/
https://www.ncbi.nlm.nih.gov/pubmed/28045021
http://dx.doi.org/10.1038/ncomms13958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216056/
https://www.ncbi.nlm.nih.gov/pubmed/28045021
http://dx.doi.org/10.1038/ncomms13958

Ejemplares similares